Mr John Llewellyn Stubbs, AA-C - Medicare Anesthesiology Assistant in Marietta, GA

Mr John Llewellyn Stubbs, AA-C is a medicare enrolled "Anesthesiologist Assistant" in Marietta, Georgia. He went to Emory University School Of Medicine and graduated in 1998 and has 26 years of diverse experience with area of expertise as Anesthesiology Assistant. He is a member of the group practice Georgia Group Services, Llc and his current practice location is 531 Roselane St Nw, Marietta, Georgia. You can reach out to his office (for appointments etc.) via phone at (770) 794-0477.

Mr John Llewellyn Stubbs is licensed to practice in Georgia (license number 003175) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1801984489.

Contact Information

Mr John Llewellyn Stubbs, AA-C
531 Roselane St Nw,
Marietta, GA 30060-6913
(770) 794-0477
Not Available



Provider's Profile

Full NameMr John Llewellyn Stubbs
GenderMale
SpecialityAnesthesiology Assistant
Experience26 Years
Location531 Roselane St Nw, Marietta, Georgia
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Mr John Llewellyn Stubbs attended and graduated from Emory University School Of Medicine in 1998
  NPI Data:
  • NPI Number: 1801984489
  • Provider Enumeration Date: 10/10/2006
  • Last Update Date: 07/08/2007
  Medicare PECOS Information:
  • PECOS PAC ID: 4183689292
  • Enrollment ID: I20041130000665

Medical Identifiers

Medical identifiers for Mr John Llewellyn Stubbs such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1801984489NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
367H00000XAnesthesiologist Assistant 003175 (Georgia)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Floyd Medical CenterRome, GAHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Georgia Group Services, Llc084033801866

News Archive

TUM scientists shed new light on metastases in the liver at early stage of pancreatic cancer

Pancreatic cancer is an exceptionally aggressive type of cancer. Frequently, metastases already start to grow in other organs, particularly often in the liver, before the original tumor was even detected.

BIOREM announces 4 new orders totalling $1.5 million

BIOREM Inc. today announced four new orders totalling $1.5 million. The orders include a biogas conditioning system and an odour control system in North America, as well as an industrial VOC/odour abatement system in Asia and a small odour control system in the Middle East.

Bio-Path initiates enrollment in fourth cohort of Liposomal Grb-2 Phase I trial for blood cancers

Bio-Path Holdings, Inc., a biotechnology company developing a liposomal delivery technology for nucleic acid cancer drugs, today announced that it has begun enrolling patients into the fourth dosage cohort in its Phase I clinical trial of its lead product candidate, BP-100.1.01 (Liposomal Grb-2), which is being evaluated as a systemic treatment for blood cancers including acute myeloid leukemia (AML), chronic myelogenous leukemia (CML), acute lymphoblastic leukemia (ALL) and myelodysplastic syndrome (MDS).

Gates Foundation, Canadian Government announce initiative to develop HIV/AIDS vaccine

Bill Gates, co-founder of the Bill & Melinda Gates Foundation, and Canadian Prime Minister Stephen Harper on Tuesday announced a joint $139 million initiative to establish a research institute for the development of an HIV/AIDS vaccine, Toronto's Globe and Mail reports.

Arrayit achieves technological breakthrough in microarray production

Arrayit Corporation, a life sciences and healthcare technology leader, today announced that the Company has made a technological breakthrough in the speed and efficiency by which it manufactures its proprietary microarrays, which are tiny glass substrates that contain rows and columns of printed spots used for scientific research and molecular diagnostics.

Read more Medical News

› Verified 2 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Mr John Llewellyn Stubbs allows following entities to bill medicare on his behalf.
Entity NameGeorgia Group Services, Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1093947236
PECOS PAC ID: 0840338018
Enrollment ID: O20091109000203

News Archive

TUM scientists shed new light on metastases in the liver at early stage of pancreatic cancer

Pancreatic cancer is an exceptionally aggressive type of cancer. Frequently, metastases already start to grow in other organs, particularly often in the liver, before the original tumor was even detected.

BIOREM announces 4 new orders totalling $1.5 million

BIOREM Inc. today announced four new orders totalling $1.5 million. The orders include a biogas conditioning system and an odour control system in North America, as well as an industrial VOC/odour abatement system in Asia and a small odour control system in the Middle East.

Bio-Path initiates enrollment in fourth cohort of Liposomal Grb-2 Phase I trial for blood cancers

Bio-Path Holdings, Inc., a biotechnology company developing a liposomal delivery technology for nucleic acid cancer drugs, today announced that it has begun enrolling patients into the fourth dosage cohort in its Phase I clinical trial of its lead product candidate, BP-100.1.01 (Liposomal Grb-2), which is being evaluated as a systemic treatment for blood cancers including acute myeloid leukemia (AML), chronic myelogenous leukemia (CML), acute lymphoblastic leukemia (ALL) and myelodysplastic syndrome (MDS).

Gates Foundation, Canadian Government announce initiative to develop HIV/AIDS vaccine

Bill Gates, co-founder of the Bill & Melinda Gates Foundation, and Canadian Prime Minister Stephen Harper on Tuesday announced a joint $139 million initiative to establish a research institute for the development of an HIV/AIDS vaccine, Toronto's Globe and Mail reports.

Arrayit achieves technological breakthrough in microarray production

Arrayit Corporation, a life sciences and healthcare technology leader, today announced that the Company has made a technological breakthrough in the speed and efficiency by which it manufactures its proprietary microarrays, which are tiny glass substrates that contain rows and columns of printed spots used for scientific research and molecular diagnostics.

Read more Medical News

› Verified 2 days ago

Entity NameConcordia Anesthesiology Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1619296464
PECOS PAC ID: 8325172885
Enrollment ID: O20100819000220

News Archive

TUM scientists shed new light on metastases in the liver at early stage of pancreatic cancer

Pancreatic cancer is an exceptionally aggressive type of cancer. Frequently, metastases already start to grow in other organs, particularly often in the liver, before the original tumor was even detected.

BIOREM announces 4 new orders totalling $1.5 million

BIOREM Inc. today announced four new orders totalling $1.5 million. The orders include a biogas conditioning system and an odour control system in North America, as well as an industrial VOC/odour abatement system in Asia and a small odour control system in the Middle East.

Bio-Path initiates enrollment in fourth cohort of Liposomal Grb-2 Phase I trial for blood cancers

Bio-Path Holdings, Inc., a biotechnology company developing a liposomal delivery technology for nucleic acid cancer drugs, today announced that it has begun enrolling patients into the fourth dosage cohort in its Phase I clinical trial of its lead product candidate, BP-100.1.01 (Liposomal Grb-2), which is being evaluated as a systemic treatment for blood cancers including acute myeloid leukemia (AML), chronic myelogenous leukemia (CML), acute lymphoblastic leukemia (ALL) and myelodysplastic syndrome (MDS).

Gates Foundation, Canadian Government announce initiative to develop HIV/AIDS vaccine

Bill Gates, co-founder of the Bill & Melinda Gates Foundation, and Canadian Prime Minister Stephen Harper on Tuesday announced a joint $139 million initiative to establish a research institute for the development of an HIV/AIDS vaccine, Toronto's Globe and Mail reports.

Arrayit achieves technological breakthrough in microarray production

Arrayit Corporation, a life sciences and healthcare technology leader, today announced that the Company has made a technological breakthrough in the speed and efficiency by which it manufactures its proprietary microarrays, which are tiny glass substrates that contain rows and columns of printed spots used for scientific research and molecular diagnostics.

Read more Medical News

› Verified 2 days ago

Entity NameMak Anesthesia Cobb Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1699045070
PECOS PAC ID: 7810154960
Enrollment ID: O20120201000868

News Archive

TUM scientists shed new light on metastases in the liver at early stage of pancreatic cancer

Pancreatic cancer is an exceptionally aggressive type of cancer. Frequently, metastases already start to grow in other organs, particularly often in the liver, before the original tumor was even detected.

BIOREM announces 4 new orders totalling $1.5 million

BIOREM Inc. today announced four new orders totalling $1.5 million. The orders include a biogas conditioning system and an odour control system in North America, as well as an industrial VOC/odour abatement system in Asia and a small odour control system in the Middle East.

Bio-Path initiates enrollment in fourth cohort of Liposomal Grb-2 Phase I trial for blood cancers

Bio-Path Holdings, Inc., a biotechnology company developing a liposomal delivery technology for nucleic acid cancer drugs, today announced that it has begun enrolling patients into the fourth dosage cohort in its Phase I clinical trial of its lead product candidate, BP-100.1.01 (Liposomal Grb-2), which is being evaluated as a systemic treatment for blood cancers including acute myeloid leukemia (AML), chronic myelogenous leukemia (CML), acute lymphoblastic leukemia (ALL) and myelodysplastic syndrome (MDS).

Gates Foundation, Canadian Government announce initiative to develop HIV/AIDS vaccine

Bill Gates, co-founder of the Bill & Melinda Gates Foundation, and Canadian Prime Minister Stephen Harper on Tuesday announced a joint $139 million initiative to establish a research institute for the development of an HIV/AIDS vaccine, Toronto's Globe and Mail reports.

Arrayit achieves technological breakthrough in microarray production

Arrayit Corporation, a life sciences and healthcare technology leader, today announced that the Company has made a technological breakthrough in the speed and efficiency by which it manufactures its proprietary microarrays, which are tiny glass substrates that contain rows and columns of printed spots used for scientific research and molecular diagnostics.

Read more Medical News

› Verified 2 days ago

Entity NameMak Anesthesia, Nw Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1609202720
PECOS PAC ID: 4880820315
Enrollment ID: O20131111001715

News Archive

TUM scientists shed new light on metastases in the liver at early stage of pancreatic cancer

Pancreatic cancer is an exceptionally aggressive type of cancer. Frequently, metastases already start to grow in other organs, particularly often in the liver, before the original tumor was even detected.

BIOREM announces 4 new orders totalling $1.5 million

BIOREM Inc. today announced four new orders totalling $1.5 million. The orders include a biogas conditioning system and an odour control system in North America, as well as an industrial VOC/odour abatement system in Asia and a small odour control system in the Middle East.

Bio-Path initiates enrollment in fourth cohort of Liposomal Grb-2 Phase I trial for blood cancers

Bio-Path Holdings, Inc., a biotechnology company developing a liposomal delivery technology for nucleic acid cancer drugs, today announced that it has begun enrolling patients into the fourth dosage cohort in its Phase I clinical trial of its lead product candidate, BP-100.1.01 (Liposomal Grb-2), which is being evaluated as a systemic treatment for blood cancers including acute myeloid leukemia (AML), chronic myelogenous leukemia (CML), acute lymphoblastic leukemia (ALL) and myelodysplastic syndrome (MDS).

Gates Foundation, Canadian Government announce initiative to develop HIV/AIDS vaccine

Bill Gates, co-founder of the Bill & Melinda Gates Foundation, and Canadian Prime Minister Stephen Harper on Tuesday announced a joint $139 million initiative to establish a research institute for the development of an HIV/AIDS vaccine, Toronto's Globe and Mail reports.

Arrayit achieves technological breakthrough in microarray production

Arrayit Corporation, a life sciences and healthcare technology leader, today announced that the Company has made a technological breakthrough in the speed and efficiency by which it manufactures its proprietary microarrays, which are tiny glass substrates that contain rows and columns of printed spots used for scientific research and molecular diagnostics.

Read more Medical News

› Verified 2 days ago

Entity NameMak Anesthesia Holdings, Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1912452939
PECOS PAC ID: 4284917204
Enrollment ID: O20170216001563

News Archive

TUM scientists shed new light on metastases in the liver at early stage of pancreatic cancer

Pancreatic cancer is an exceptionally aggressive type of cancer. Frequently, metastases already start to grow in other organs, particularly often in the liver, before the original tumor was even detected.

BIOREM announces 4 new orders totalling $1.5 million

BIOREM Inc. today announced four new orders totalling $1.5 million. The orders include a biogas conditioning system and an odour control system in North America, as well as an industrial VOC/odour abatement system in Asia and a small odour control system in the Middle East.

Bio-Path initiates enrollment in fourth cohort of Liposomal Grb-2 Phase I trial for blood cancers

Bio-Path Holdings, Inc., a biotechnology company developing a liposomal delivery technology for nucleic acid cancer drugs, today announced that it has begun enrolling patients into the fourth dosage cohort in its Phase I clinical trial of its lead product candidate, BP-100.1.01 (Liposomal Grb-2), which is being evaluated as a systemic treatment for blood cancers including acute myeloid leukemia (AML), chronic myelogenous leukemia (CML), acute lymphoblastic leukemia (ALL) and myelodysplastic syndrome (MDS).

Gates Foundation, Canadian Government announce initiative to develop HIV/AIDS vaccine

Bill Gates, co-founder of the Bill & Melinda Gates Foundation, and Canadian Prime Minister Stephen Harper on Tuesday announced a joint $139 million initiative to establish a research institute for the development of an HIV/AIDS vaccine, Toronto's Globe and Mail reports.

Arrayit achieves technological breakthrough in microarray production

Arrayit Corporation, a life sciences and healthcare technology leader, today announced that the Company has made a technological breakthrough in the speed and efficiency by which it manufactures its proprietary microarrays, which are tiny glass substrates that contain rows and columns of printed spots used for scientific research and molecular diagnostics.

Read more Medical News

› Verified 2 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mr John Llewellyn Stubbs is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Mr John Llewellyn Stubbs, AA-C
1472 Hedgewood Ln Nw,
Kennesaw, GA 30152-4513

Ph: (770) 419-5867
Mr John Llewellyn Stubbs, AA-C
531 Roselane St Nw,
Marietta, GA 30060-6913

Ph: (770) 794-0477

News Archive

TUM scientists shed new light on metastases in the liver at early stage of pancreatic cancer

Pancreatic cancer is an exceptionally aggressive type of cancer. Frequently, metastases already start to grow in other organs, particularly often in the liver, before the original tumor was even detected.

BIOREM announces 4 new orders totalling $1.5 million

BIOREM Inc. today announced four new orders totalling $1.5 million. The orders include a biogas conditioning system and an odour control system in North America, as well as an industrial VOC/odour abatement system in Asia and a small odour control system in the Middle East.

Bio-Path initiates enrollment in fourth cohort of Liposomal Grb-2 Phase I trial for blood cancers

Bio-Path Holdings, Inc., a biotechnology company developing a liposomal delivery technology for nucleic acid cancer drugs, today announced that it has begun enrolling patients into the fourth dosage cohort in its Phase I clinical trial of its lead product candidate, BP-100.1.01 (Liposomal Grb-2), which is being evaluated as a systemic treatment for blood cancers including acute myeloid leukemia (AML), chronic myelogenous leukemia (CML), acute lymphoblastic leukemia (ALL) and myelodysplastic syndrome (MDS).

Gates Foundation, Canadian Government announce initiative to develop HIV/AIDS vaccine

Bill Gates, co-founder of the Bill & Melinda Gates Foundation, and Canadian Prime Minister Stephen Harper on Tuesday announced a joint $139 million initiative to establish a research institute for the development of an HIV/AIDS vaccine, Toronto's Globe and Mail reports.

Arrayit achieves technological breakthrough in microarray production

Arrayit Corporation, a life sciences and healthcare technology leader, today announced that the Company has made a technological breakthrough in the speed and efficiency by which it manufactures its proprietary microarrays, which are tiny glass substrates that contain rows and columns of printed spots used for scientific research and molecular diagnostics.

Read more News

› Verified 2 days ago


Anesthesiologist Assistant Nurses in Marietta, GA

Whitney Morrow,
Anesthesiologist Assistant
Medicare: May Accept Medicare Assignments
Practice Location: 531 Roselane St Nw, Suite 750, Marietta, GA 30060
Phone: 770-794-0477    
Matthew D Carpenter, AAC
Anesthesiologist Assistant
Medicare: Accepting Medicare Assignments
Practice Location: 677 Church St Ne, Marietta, GA 30060
Phone: 770-794-0477    Fax: 770-794-3108
Eva Silvey Leonard, PAA
Anesthesiologist Assistant
Medicare: Accepting Medicare Assignments
Practice Location: 2540 Windy Hill Rd Se, Marietta, GA 30067
Phone: 770-644-1274    
Luke Wilkins,
Anesthesiologist Assistant
Medicare: Accepting Medicare Assignments
Practice Location: 677 Church St Ne, Marietta, GA 30060
Phone: 770-794-0477    Fax: 770-794-3108
Jordan Batson Cawley, CAA
Anesthesiologist Assistant
Medicare: Accepting Medicare Assignments
Practice Location: 677 Church St Ne, Marietta, GA 30060
Phone: 770-793-5000    
Mrs. Amber Toman, PAA
Anesthesiologist Assistant
Medicare: Accepting Medicare Assignments
Practice Location: 677 Church St Ne, Marietta, GA 30060
Phone: 770-794-0477    
Mary Curran Dewyngaert, PA-AA
Anesthesiologist Assistant
Medicare: Accepting Medicare Assignments
Practice Location: 677 Church St Ne, Marietta, GA 30060
Phone: 770-794-0477    Fax: 770-794-3108

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.